UBS Affirms Neutral on Apple, $296 PT

Sep 18, 2026· Analyst: David Vogt· 1 min read· Reproduced verbatim
Rating
Hold
Price target
$296
Previous
Implied downside
-12%

UBS analyst David Vogt reiterated a Neutral rating and $296.00 price target on Apple (NASDAQ: AAPL)

“UBS Evidence Lab data that tracks iPhone availability across 30+ geographies suggests muted demand for the iPhone 18 Pro and Pro Max since preorders began last Saturday.

For context, we believe YoY comparisons are more meaningful in determining underlying demand. On average, wait times for the Pro Max are ~23 days, ~2 days shorter YoY.

Flattish YoY wait times in the UK and Japan were offset by shorter (~4 days YoY) wait times in China. Average wait times for the Pro were ~16 days, shorter by ~2 days YoY as well.

Notably, the US was the only region where wait times were up (~1 day YoY) for the Pro, whereas wait times in China were materially shorter (~10 days YoY).

However, we note that the wait time data—particularly in China—could be impacted by consumers waiting for the launch of the Duo next month.

In our view, the initial muted wait times are likely due to solid LTM demand for the iPhone 17 series, incremental changes to the Pro and Pro Max, as well as higher ASPs.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Share

Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.